Extended Data Fig. 12: BLI assay for XGv347 competing with XGv289, XGv282 and XGv265.
From: Memory B cell repertoire from triple vaccinees against diverse SARS-CoV-2 variants
Affinity curves of XGv347 to Omicron S protein competing with a, XGv265, b, XGv282 and c, XGv289. In each panel, (left) XGv347 was first injected, followed by the XGv265, XGv282 and XGv289 in a–c, respectively. (right) Also, XGv265 in a, XGv282 in b and XGv289 in c, was injected first and competed with the second injection of XGv347. Each curve is a representative of three independent experiments.
